Browse > Article

Epidemiology, clinical manifestations, and management of pandemic novel Influenza A (H1N1)  

Kim, Woo-Joo (Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine)
Publication Information
The Korean Journal of Medicine / v.77, no.2, 2009 , pp. 157-164 More about this Journal
Abstract
Since the first case with swine origin influenza A (H1N1) infection has been described in Mexico and the United States in April 2009, novel influenza A (H1N1) virus has been spread to all over the world. WHO has officially declared the outbreak to be an influenza pandemic by 11 June. The number of human cases and death of pandemic A (H1N1) 2009 is still increasing substantially in many countries with widespread community transmission. The natural course of novel influenza A (H1N1) still appears to be generally mild and mostly recovered. It predominantly affects children and young adults with relative sparing of older age groups, supporting a theory that older people have some cross-reactive antibodies to novel influenza A (H1N1) from previous infection or immunization. People with chronic medical conditions and pregnancy are more likely to be hospitalized with or dead from the novel influenza A (H1N1). Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended mainly for all hospitalized patients with novel influenza (H1N1) and patients who are at higher risk for seasonal influenza complications. Continued pandemic preparedness, flexible response and careful monitoring are essential because influenza viruses are unpredictable. This article reviews the current epidemiology, clinical manifestations, and management of pandemic novel influenza A (H1N1).
Keywords
Influenza A (H1N1); Pandemic; Epidemiology; Management;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 WHO. New influenza A (H1N1) virus: global epidemiological situation, 19 June 2009. Weekly Epidemiological Record 84:249-256, 2009
2 CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 58:521-524, 2009
3 WHO. Influenza A(H1N1) - update 42. 3 June 2009
4 Kaufman MA, Duke GJ, McGain F, French C, Aboltins C, Lane G, Gutteridge GA. Life-threatening respiratory failure from H1N1 influenza 09 (human swine influenza). MJA 191:214-216, 2009
5 CDC. Interim guidance on specimen collection, processing, and testing for patients with suspected swine-origin influenza A (H1N1) virus infection. 2009
6 Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med 2009 Jun 29 [Epub ahead of print]   DOI   ScienceOn
7 CDC. Interim guidance on antiviral recommendations for patients with confirmed or suspected swine influenza A (H1N1) virus infection and close contacts. 2009
8 WHO. Influenza-like illness in the United States and Mexico. 24 April 2009
9 WHO. Pandemic (H1N1) 2009 - update 58. July 6, 2009
10 WHO. World now at the start of 2009 influenza pandemic. 11 June 2009
11 Ginochio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, Lotlikar M, Kowerska M, Becker G, Korologos D, de Geronimo M, Crawford JM. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 45:191-195, 2009   DOI   ScienceOn
12 CDC. Interim guidance—pregnant women and swine influenza: considerations for clinicians. 2009
13 CDC. Novel influenza A(H1N1) virus infections among healthcare personnel - United States, April-May 2009. MMWR 58: 641-645, 2009
14 Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325:197-201, 2009⨀Ā삟?⨀ऄ돀類?⨀塨?⨀䃣⨀ꡪ?⨀댐䡑ࠄ⣡̀倀胅?⨀ȀᘀĀ졦?⨀㣢Ȁ倀悼?⨀ȀᘀĀ⁧?⨀샢܀倀㡦?⨀ఐ܀Ā硧?⨀䣣܀倀큥?⨀ఐ܀Ā큧?⨀탣܀倀桥?⨀ఐ܀Ā⡨?⨀壤Ȁ倀e?⨀ȀᘀĀ聨?⨀냡紅倀顤?⨀ȁᘀĀ𪎖⨀Ā倀つ?⨀ȀᘀĀど?⨀낗䒳က倀ꁣ?⨀ᜒကĀ衩?⨀㢘䒳Ȁ倀㡣?⨀ȀᘀĀ?⨀삘䒳Ѐ倀큢?⨀ȀᘀĀ㡪?⨀餂돀類?⨀塨?⨀䃣⨀ᢻ?⨀䤀대⥫̄Ѐ㄀대롪?⨀꩑ࠄ섂̀￿￿Ā㤀대k?⨀꩑ࠄ佄䍉偁剔䥎䙏န﾿缀㄀대に?⨀꩑ࠄ聪?⨀넀대桫?⨀띑ࠄ?⨀䃣⨀̀̀耀 ㌀띑ࠄ?⨀聫?⨀ĀᘀԀ䡫?⨀ఀ Ԁᡫ?⨀Ȁ᠀Ԁ돐顫?⨀⨀⨀䃣⨀̀̀耀　㈀鹑ࠄ顬?⨀ȈᘀĀ   DOI   PUBMED   ScienceOn
15 Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C. WHO Rapid Pandemic Assessment Collaboration. Pandemic potential of a novel strain of influenza A (H1N1): early findings. Science 324:1557-1561, 2009   DOI   PUBMED   ScienceOn
16 CDC. Interim guidance for screening for swine-origin influenza A (H1N1) by state and local health departments, hospitals, and clinicians in regions with few or no reported cases of swine influenza A (H1N1). 2009
17 Press release #42-09: community transmission of H1N1 flu appears to decline in New York City. New York City Department of Health and Mental Hygiene, 2009. (http://www.nyc.gov/html/doh/ html/pr2009/pr042-09.shtml; accessed June 2009)
18 Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Hiroshi Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009 (published online Jul 13)   DOI   ScienceOn
19 Reuters. Roche finds 1st case of H1N1 resistance to Tamiflu. June 29, 2009
20 CDC. Neurologic complications associated with novel influenza A (H1N1) virus infection in children--Dallas, Texas, May 2009. MMWR 58:773-778, 2009
21 Reuters. UPDATE 2-Japan finds first case of H1N1 resistant to Tamiflu. July 2, 2009
22 Zimmer SM, Burke DS. Historical perspective—emergence of influenza A (H1N1) viruses. N Engl J Med 361:279-285, 2009   DOI   PUBMED   ScienceOn
23 Senanayake SN. Swine flu update: bringing home the bacon. MJA 191:1-3, 2009
24 WHO. Pandemic (H1N1) 2009 briefing note 4. July 24 2009
25 Nishiura H, Castillo-Chavez C, Safan M, Chowell G. Transmission potential of the new influenza A (H1N1) virus and its age-specificity in Japan. Euro Surveill 14:19227, 2009
26 Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, Fraser C, Ferguson NM, Ghani AC. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 339:b2840, 2009   DOI   ScienceOn
27 WHO. Changes in reporting requirements for pandemic (H1N1) 2009 virus infection. July 16, 2009